Matinas BioPharma Holdings, Inc. (MTNB) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Matinas BioPharma Holdings, Inc. (MTNB) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

MTNB Income Statement

Matinas BioPharma Holdings, Inc. (MTNB) annual income statement — 14-year revenue, gross profit & net income history

Annual Quarterly

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1M	1.06M	1.06M	1.06M	0	-333	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-100%	-100%	-100%	-100%	-	-	-	-	-100%	-100.53%	-100%
Cost of Goods Sold	4K	74K	-85K	114K	124K	85K	2.38M	2.24M	3.37M	240K	3.67M	3.29M	3.56M	3.97M	3.87M	3.71M	4.13M	4.98M	4.24M	4.62M
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	362.23%	363.78%	348.73%	388.24%	-	-1273137.84%	-
Gross Profit	-4K	-74K	85K	-114K	-124K	-85K	-2.38M	-2.24M	-3.37M	-240K	-3.67M	-3.29M	-3.56M	-2.87M	-2.8M	-2.64M	-3.06M	-4.98M	-4.24M	-4.62M
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-262.23%	-263.78%	-248.73%	-288.24%	-	1273237.84%	-
Gross Profit Growth %	96.77%	12.94%	103.58%	94.91%	96.32%	64.58%	35.17%	32.05%	5.28%	91.65%	-30.71%	-24.62%	-16.16%	42.27%	33.87%	42.79%	-23.51%	-55.17%	-22.43%	-42.61%
Operating Expenses	1.55M	1.86M	1.69M	1.46M	1.71M	1.86M	6.09M	2.14M	2.47M	5.66M	2.22M	2.84M	2.6M	2.71M	2.68M	2.82M	2.86M	2.74M	2.47M	2.26M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	247.45%	251.74%	265.1%	269.14%	-	-743055.56%	-
Selling, General & Admin	1.55M	1.94M	1.6M	1.46M	1.71M	1.86M	1.66M	2.14M	2.47M	2.22M	2.22M	2.84M	2.6M	2.71M	2.68M	2.82M	2.86M	2.74M	2.47M	2.26M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	247.45%	251.74%	265.1%	269.14%	-	-743055.56%	-
Research & Development	0	0	0	0	0	85K	2.38M	2.24M	3.37M	3.45M	3.67M	3.29M	3.56M	3.97M	3.87M	3.71M	4.13M	4.98M	4.24M	4.62M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	362.23%	363.78%	348.73%	388.24%	-	-1273137.84%	-
Other Operating Expenses	0	-74K	85K	0	0	-85K	1000K	-1000K	-1000K	0	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K
Operating Income	-1.55M	-1.94M	-1.6M	-1.58M	-1.84M	-1.95M	-8.47M	-4.38M	-5.84M	-5.9M	-5.89M	-6.13M	-6.16M	-5.59M	-5.48M	-5.46M	-5.92M	-7.72M	-6.71M	-6.88M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-509.67%	-515.52%	-513.83%	-557.38%	-	2016293.39%	-
Operating Income Growth %	15.35%	0.51%	81.11%	64%	68.54%	67.03%	-43.86%	28.58%	5.2%	-5.66%	-7.43%	-12.3%	-3.95%	27.66%	18.38%	20.59%	-23.7%	-21.55%	-3.47%	-22.72%
EBITDA	-1.55M	-1.86M	-1.18M	-1.46M	-1.71M	-1.82M	-8.22M	-4.14M	-5.6M	-5.66M	-5.79M	-6.03M	-6.06M	-5.49M	-5.38M	-5.37M	-5.83M	-7.65M	-6.64M	-6.81M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-500.82%	-506.4%	-505.17%	-548.73%	-	1994888.29%	-
EBITDA Growth %	9.46%	-2.42%	85.68%	64.64%	69.4%	67.89%	-42.03%	31.42%	7.64%	-3.15%	-7.54%	-12.37%	-3.91%	28.22%	18.97%	21.11%	-23.52%	-21.72%	-3.43%	-22.91%
D&A (Non-Cash Add-back)	4K	74K	423K	114K	124K	128K	247K	243K	241K	240K	98K	100K	98K	97K	97K	92K	92K	75K	71.28K	70.86K
EBIT	-1.78M	-1.92M	-1.03M	-2.15M	-5.25M	-1.66M	-4.04M	-4.28M	-5.72M	-5.82M	-5.31M	-6.05M	-6.06M	-5.51M	-3.63M	-5.46M	-5.92M	-5.98M	-6.7M	-6.84M
Net Interest Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	229K	15K	-312K	-573K	-3.41M	290K	-44K	106K	120K	78K	573K	79K	99K	73K	1.85M	988	2K	1.74M	15.23K	41.39K
Pretax Income	-1.33M	-1.92M	-1.91M	-2.15M	-5.25M	-1.66M	-8.51M	-4.28M	-5.72M	-5.82M	-5.31M	-6.05M	-6.06M	-5.51M	-3.63M	-5.46M	-5.92M	-5.98M	-6.7M	-6.84M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-503.01%	-341.86%	-513.83%	-557.2%	-	2011719.22%	-
Income Tax	0	0	0	0	0	0	-80K	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0.94%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-1.33M	-1.92M	-1.91M	-2.15M	-5.25M	-1.66M	-8.43M	-4.28M	-5.72M	-5.82M	-5.31M	-6.05M	-6.06M	-5.51M	-3.63M	-5.46M	-5.92M	-5.98M	-6.7M	-6.84M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-503.01%	-341.86%	-513.83%	-557.2%	-	2011719.22%	-
Net Income Growth %	74.72%	-16%	77.33%	49.71%	8.29%	71.57%	-58.69%	29.4%	5.63%	-5.64%	-46.23%	-10.86%	-2.31%	7.78%	45.75%	20.11%	-23.62%	-20.61%	-5.65%	-25.45%
Net Income (Continuing)	-1.33M	-1.92M	-1.91M	-2.15M	-5.25M	-1.66M	-8.43M	-4.28M	-5.72M	-5.82M	-5.31M	-6.05M	-6.06M	-5.51M	-3.63M	-5.46M	-5.92M	-5.98M	-6.7M	-6.84M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-3.15	-4.50	-4.50	-6.00	-15.45	-4.95	-25.95	-12.75	-17.25	-20.10	-1.22	-1.39	-1.39	-1.25	-0.01	-1.26	-1.36	-0.58	-1.55	-1.59
EPS Growth %	79.61%	9.09%	82.66%	52.94%	10.43%	75.37%	-2027.05%	-817.27%	-1141.01%	-1508%	-	-10.32%	-2.21%	-115.52%	99.52%	20.75%	-16.24%	52.46%	2.52%	-16.06%
EPS (Basic)	-3.15	-4.50	-4.50	-6.00	-15.45	-4.95	-25.95	-12.75	-17.25	-20.10	-1.22	-1.39	-1.39	-1.25	-0.01	-1.26	-1.36	-0.58	-1.55	-1.59
Diluted Shares Outstanding	427.08K	427.08K	364.94K	362.39K	339.13K	339.13K	324.39K	335.86K	332.47K	289.81K	4.35M	4.35M	4.35M	4.35M	4.34M	4.34M	4.34M	4.33M	4.33M	4.3M
Basic Shares Outstanding	427.08K	427.08K	364.94K	362.39K	339.13K	339.13K	324.39K	335.86K	332.47K	289.81K	4.35M	4.35M	4.35M	4.35M	4.34M	4.34M	4.34M	4.33M	4.33M	4.3M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-